First Trust Advisors
JNCE

First Trust Advisors’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

First Trust Advisors’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-72,807
Closed -$495K – 2676
2021
Q2 		$495K Buy
72,807
+13,103
+22% +$89.1K ﹤0.01% 2283
2021
Q1 		$613K Buy
59,704
+18,246
+44% +$187K ﹤0.01% 2149
2020
Q4 		$290K Sell
41,458
-1,616
-4% -$11.3K ﹤0.01% 2228
2020
Q3 		$351K Buy
+43,074
New +$351K ﹤0.01% 2127